Anaptysbio (ANAB) Debt Ratio (2016 - 2019)

Anaptysbio (ANAB) posted Debt Ratio of 0.01 for Q3 2019, down 31.32% on a QoQ basis from 0.01 in Q2 2019, and up 49.1% year-over-year from 0.0 in Q3 2018.

Anaptysbio (ANAB) Debt Ratio (2016 - 2019) Analysis & Trends

Anaptysbio's Debt Ratio history runs 4 years deep, the most recent figure standing at 0.01 for Q3 2019.

  • Quarterly Debt Ratio rose 49.1% year-over-year to 0.01 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was 0.01 (up 49.1% YoY) and the FY2018 annual result came in at 0.0, down 94.65% from the prior year.
  • Debt Ratio was 0.01 for Q3 2019 at Anaptysbio, down from 0.01 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.22 in Q4 2016 and bottomed at 0.0 in Q4 2018.
  • A 4-year average of 0.05 and a median of 0.02 in 2018 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2018 — Debt Ratio tumbled 94.65% — and 2019, when it soared 49.1%.
  • Anaptysbio's Debt Ratio stood at 0.22 in 2016, then slumped by 89.67% to 0.02 in 2017, then tumbled by 94.65% to 0.0 in 2018, then soared by 459.16% to 0.01 in 2019.
  • Business Quant data shows ANAB's Debt Ratio at 0.01 in Q3 2019, 0.01 in Q2 2019, and 0.01 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 1.41
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.11
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.05
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Anaptysbio 1.58 Bn 1.29 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2019 0.01
Jun 30, 2019 0.01
Mar 31, 2019 0.01
Dec 31, 2018 0.00
Sep 30, 2018 0.00
Jun 30, 2018 0.01
Mar 31, 2018 0.02
Dec 31, 2017 0.02
Sep 30, 2017 0.08
Jun 30, 2017 0.08
Mar 31, 2017 0.10
Dec 31, 2016 0.22